Morningstar
•
Oct 30, 2026
DaVita Inc.: DaVita Earnings: 2026 Outlook Boost More Muted Than Market Anticipated
Summary
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Technical Assessment: Bullish in the Intermediate-Term
Oct 30, 2026
•
TRGP, DGX
Analyst Report: ResMed Inc.
Oct 30, 2026
•
RMD
Analyst Report: Aon plc
Oct 29, 2026
•
AON
Analyst Report: Centene Corp
Oct 29, 2026
•
CNC
Market Digest: BIIB, CMCSA, CNC, IEX, NEM, RCL, RTX, WEN, V, GNRC, CLF, HOOD, SOFI
Oct 29, 2026
•
WEN, CMCSA, V, RTX, NEM, GNRC, CNC, SOFI, RCL, CLF, IEX, HOOD, BIIB
Analyst Profile
Julie Utterback
Senior Analyst
Julie Utterback is a senior equity analyst for Morningstar Research Services LLC, a wholly owned subsidiary of Morningstar, Inc. She covers life sciences firms in the healthcare industry.Utterback initially joined Morningstar in 2005 as an equity analyst in the healthcare industry. At that time, she covered medical technology companies, including orthopedic device, medical equipment, and cardiac device firms. In 2010, she joined Morningstar's credit research team, initiating coverage on the entire healthcare industry and generally helping the organization expand and maintain its credit coverage across many industries. She held that senior credit analyst role until rejoining the equity team in April 2019.Prior to joining Morningstar, Utterback was an equity analyst at State Farm Insurance for several years. She holds a bachelor's degree in finance from the University of Illinois Urbana- Champaign. She also holds the Chartered Financial Analyst® designation.
